Myelodysplastic–myeloproliferative diseases
| Myelodysplastic-myeloproliferative diseases | |
|---|---|
| Classification and external resources | |
| MeSH | D054437 |
Myelodysplastic–myeloproliferative diseases are a category of hematological malignancies disorders created by the World Health Organization which have characteristics of both myelodysplastic and myeloproliferative conditions.
When a hematological malignancy is characterised by normal differentiation of cells of myeloid cell line, it is referred to as myeloproliferative. On the other hand, when there is abnormal differentiation of cells of myeloid cell line, it is referred to as myelodysplastic.
External links
- http://www.meb.uni-bonn.de/cancer.gov/CDR0000334473.html
- http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_myelodysplastic_syndrome_65.asp
- http://www.cancer.gov/cancertopics/pdq/treatment/mds-mpd/Patient
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, June 07, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.